NEMIC Fellows Receive Nearly $200K from Commerce RI's Innovation Voucher Program
Further demonstrating the exceptional talent that exists within the NEMIC community, several of our fellow companies were recently named 2023 Innovation Voucher Award recipients.
Facilitated by Commerce RI, the Innovation Voucher Awards provides up to $50,000 in grant money to selected companies with 500 employees or fewer. Recipients can apply the funds in various ways, including toward the commercialization of new products, processes, or services; accessing scientific, engineering, and design expertise; and facilitating the scale-to-market development of innovative ideas.
“These vouchers provide a great opportunity for our NEMIC fellow companies to enhance their innovative projects and further contribute to the growth of our community's business landscape,” said NEMIC Co-Founder Aidan Petrie. “We applaud Commerce RI for their continued support of innovative companies located right here in Rhode Island.”
Voucher Recipients
Kardio Status Inc., founded by Anshul Parulkar MD and Antony Chu MD, MBA received $50,000 to advance their groundbreaking work on innovative biometric signal processing algorithms using novel machine learning architectures. Their participation in our 2022 DLT Accelerator reflects their dedication to pushing the boundaries of healthcare innovation.
SMöLTAP, Inc., founded by physicians Brian Alverson, MD and Ravi D’Cruz, MD and now in the capable hand of CEO, Bob Cooper, has received $50,000 to address the unique requirements of premature babies in lumbar puncture procedures. NEMIC has been closely supporting SMöLTAP through individualized programming, leading to impressive achievements like five successful prototyping rounds, filed patents, and FDA classification confirmation.
Modesys Technologies, LLC, founded by Emanuele Raggi, was awarded $50,000 to explore a new ultrasound system for breast cancer detection in partnership with URI's Physics Department. Emanuele's involvement in NEMIC’s 2021 Med Tech Leadership Program and 2022 DLT Accelerator reflects his ongoing pursuit of excellence.
Iantrek, Inc., founded by Dave Robson, secured $49,600 to develop a precise fixture for biotissue modification, aimed at reinforcing tissues during ophthalmic surgical procedures. A dedication to advancing surgical precision is evident in Dave's participation in our 2023 NEMIC Spring Speed Pitching with Venture Cafe.
We applaud these remarkable companies and their contributions to driving innovation and improving healthcare outcomes. The NEMIC community continues to be a hub of creativity and progress, and we look forward to witnessing the impactful outcomes of these inspiring projects.